Abstract: The present disclosure provides systems and methods for brain source localization. In particular, the present disclosure provides a novel source reconstruction method (termed “TEmporally Dependent Iterative Expansion” or TEDIE), that accurately reconstructs propagating and expanding neural sources over time. The systems and method described herein can be used as a clinical tool to enhance epileptogenic zone localization and improve surgical outcomes.

Abstract: The present disclosure provides systems and methods relating to neuromodulation. In particular, the present disclosure provides systems and methods for eliminating the onset response when blocking neural conduction. The various embodiments disclosed herein include methods and systems for delivering treatment based on blocking waveforms to subjects with pathological neural activity.

Abstract: Embodiments of present disclosure provide systems and methods relating to neuromodulation. In particular, the present disclosure provides systems and methods for administering deep brain stimulation (DBS), and for evaluating the efficacy and efficiency of DBS for the treatment of neurological conditions (e.g., Parkinson's disease).

Abstract: The present disclosure provides systems and methods relating to the neuromodulation of gastrointestinal dysmotility. In particular, the present disclosure provides systems and methods for delivering temporal patterns of electrical stimulation comprising burst-patterned stimulation according to various stimulation parameters to treat gastrointestinal dysmotility disorders in a subject. The system may be implantable.

Abstract: This present disclosure provides systems and methods relating to neuromodulation. In particular, the present disclosure provides systems and methods for identifying optimized temporal patterns of spinal cord simulation (SCS) for minimizing variability in patient responses to SCS. The systems and methods of neuromodulation disclosed herein facilitate the treatment of neuropathic pain associated with various disease states and clinical indications.

Abstract: The present disclosure describes innovations to improve the use of stereo-EEG (sEEG) intreating epilepsy. The systems and methods include a fully automated platform for generating patient specific head models, a visualization of the tissue that can be recorded by a set of sEEG electrodes, an automated implantation trajectory planning algorithm that incorporates the tissue that can be recorded by a set of sEEG electrodes, and a dynamic source reconstruction algorithm that can visualize the epileptiform activity.

Abstract: A method of treating or preventing at least one symptom associated with a disease or condition in a subject in need thereof. The method comprising: stimulating a sacral nerve in the subject with an electrode according to a set of stimulation parameters; wherein the set of stimulation parameters is based on a three-dimensional model. The three-dimensional model includes a pelvic organs model, a sacral nerve model, and an electrode model. Electrode designs for stimulating a sacral nerve in a subject in need thereof.

Abstract: The present disclosure provides systems and methods for targeted nerve stimulation. In particular, the present disclosure provides systems and methods for determining the location of electrode placement providing the most therapeutic benefit for a particular subject. The various embodiments disclosed herein include methods for identifying a target nerve having the strongest representation and/or the strongest subject perception associated with a peripheral nerve in a patient-specific manner.

Abstract: The present disclosure provides systems and methods relating to the treatment of gastrointestinal dysmotility. In particular, the present disclosure provides systems and methods for delivering temporal patterns of electrical stimulation with respect to a refractory period to either suppress (e.g., treat hypermotility) or stimulate (e.g., treat hypomotility) contractions and motility in the gastrointestinal tract of a subject.

Abstract: The present disclosure describes novel systems and methods to estimate the response of neurons to electrical stimulation and to determine the optimal electrode geometry and parameters of stimulation to activate or block specific targeted groups of neurons without activation or block of non-targeted groups of neurons.

Abstract: Embodiments of the present disclosure include a method for acquiring, with a device, a plurality of electrical signals from a brain of a subject, and determining whether a biomarker is present in the plurality of electrical signals. The biomarker comprises at least one phase metric associated with the electrical signal, and further includes adjusting at least one therapy parameter based on biomarker assessment.

Abstract: The present disclosure provides systems and methods relating to neuromodulation. In particular, the present disclosure provides systems and methods for selective and/or unidirectional nerve fiber conduction block though the application of a hybrid waveform using a neuromodulation device. The systems and methods of neuromodulation disclosed herein facilitate the treatment of various diseases associated with pathological neural activity.

Abstract: The present disclosure provides systems and methods relating to neuromodulation. In particular, the present disclosure provides systems and methods for identifying optimized waveforms for blocking neural conduction. The systems and methods of neuromodulation disclosed herein facilitate the treatment of various diseases associated with pathological neural activity. The optimized waveforms for blocking neural conduction are identified through use of a global optimization algorithm based on predetermined performance criteria. A plurality of waveforms are generated and evaluated for neuronal conduction block using a computational model of extracellular neuronal stimulation, and at least on candidate waveform having an optimized shape capable of blocking neural conduction is identified.

Abstract: This present disclosure provides systems and methods relating to neuromodulation. In particular, the present disclosure provides systems and methods for identifying optimized temporal patterns of spinal cord simulation (SCS) for minimizing variability in patient responses to SCS. The systems and methods of neuromodulation disclosed herein facilitate the treatment of neuropathic pain associated with various disease states and clinical indications.

Abstract: The present disclosure provides systems and methods relating to neuromodulation. In particular, the present disclosure provides systems and methods for evaluating the efficacy of neuromodulation therapy using evoked potential (EPs). The systems and methods disclosed herein facilitate the evaluation of both parameter-dependent and system-dependent changes in EPs as indicators of therapeutic efficacy.

Abstract: This present disclosure provides systems and methods relating to neuromodulation. In particular, the present disclosure provides systems and methods for identifying optimized temporal patterns of spinal cord simulation (SCS) for minimizing variability in patient responses to SCS. The systems and methods of neuromodulation disclosed herein facilitate the treatment of neuropathic pain associated with various disease states and clinical indications.

Abstract: The present disclosure provides systems and methods for targeted nerve stimulation. In particular, the present disclosure provides systems and methods for determining the location of electrode placement providing the most therapeutic benefit for a particular subject. The various embodiments disclosed herein include methods for identifying a target nerve having the strongest representation and/or the strongest subject perception associated with a peripheral nerve in a patient-specific manner.

Abstract: The present disclosure provides systems and methods relating to neuromodulation. In particular, the present disclosure provides systems and methods for minimally invasive, targeted, vagus nerve stimulation (pVNS), and the efficacy of this approach with respect to microglial activation and the amelioration of cognitive dysfunction. The systems and methods of neuromodulation disclosed herein can be used to facilitate the treatment of various diseases associated with pathological neural activity.

Abstract: The present disclosure provides systems and methods relating to neuromodulation. In particular, the present disclosure provides systems and methods for eliminating the onset response when blocking nerve conduction. The various embodiments disclosed herein include methods for designing waveforms that block nerve conduction without inducing an onset response, and systems for delivering treatment based on these waveforms to subjects with pathological neural activity.

Abstract: The present disclosure provides systems and methods relating to neuromodulation. In particular, the present disclosure provides systems and methods for identifying optimized waveforms for blocking neural conduction. The systems and methods of neuromodulation disclosed herein facilitate the treatment of various diseases associated with pathological neural activity. The optimized waveforms for blocking neural conduction are identified through use of a global optimization algorithm based on predetermined performance criteria. A plurality of waveforms are generated and evaluated for neuronal conduction block using a computational model of extracellular neuronal stimulation, and at least on candidate waveform having an optimized shape capable of blocking neural conduction is identified.